Stroke | My Site

top of page

Home
About
All News
Contact
Advertise
More

Use tab to navigate through the menu items.

Local Ground Truth Financial + Legal News

All Posts
Finance
Legal
Real Estate
NC Intra-State
NC Intra-Government
US Federal Government
The White House
The US
The World
Health
Social Media

Mounjaro, Ozempic, Jardiance, Trulcity

Mounjaro, Ozempic, Jardiance, Trulcity

FDA Approves Mounjaro to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

The U.S. Food and Drug Administration has approved a new indication for Mounjaro (tirzepatide), Eli Lilly's widely prescribed diabetes drug, clearing it to reduce the risk of heart attack, stroke, and cardiovascular death in certain adults with type 2 diabetes. Lilly announced the approval on August 28, 2026. Mounjaro was originally approved in May 2022 as an add-on to diet and exercise to improve blood sugar control in adults and children 10 and older with type 2 diabetes, w

The Muni Bank

Aug 303 min read

Subscribe to Our Newsletter

Enter your email here*

Yes, subscribe me to your newsletter.

Home
About
All News
Contact
Advertise

© 2030 The Muni Bank. All Rights Reserved.

Unless expressly identified otherwise, all original articles, written materials, photographs, graphics, illustrations, videos, audio recordings, databases, compilations, editorial presentations, logos, trademarks, and other original content appearing on this website are the property of The Muni Bank are used under license.

No person or organization may reproduce, republish, redistribute, modify, commercially exploit, systematically archive, scrape, mirror, syndicate, or otherwise use protected content without prior written authorization, except as expressly permitted by applicable law.

bottom of page